Загрузка...
Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men
BACKGROUND: Gastroprotective agents are recommended for patients receiving low-dose aspirin (LDA) or nonsteroidal anti-inflammatory drugs (NSAIDs). Vonoprazan is a potassium-competitive acid blocker recently approved for the prevention of peptic ulcer recurrence in patients receiving LDA or NSAIDs....
Сохранить в:
| Опубликовано в: : | Clin Drug Investig |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5209422/ https://ncbi.nlm.nih.gov/pubmed/27581248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-016-0455-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|